Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liza Lindenberg

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Radiology|July 8, 2020
Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of <sup>18</sup>F-DCFPyL PET/CT with Comparison to Multiparametric MRILiza Lindenberg, Esther Mena, Baris Turkbey, et al.
Leukemia & Lymphoma|December 23, 2015
Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imagingManisha Bhutani, Baris Turkbey, Esther Tan, et al.
AJR. American Journal of Roentgenology|October 16, 2019
Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective StudyBaris Turkbey, Marcin Czarniecki, Joanna H Shih, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2021
Predictors of <sup>18</sup>F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local TherapyEsther Mena, Steven P Rowe, Joanna H Shih, et al.
Oncotarget|March 4, 2021
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumorsNaoko Takebe, Geraldine O'Sullivan Coyne, Shivaani Kummar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2026
SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST)AeRang Kim, Karla V Ballman, Pamela L Wolters, et al.
Academic Radiology|January 23, 2024
Deep Learning-Based Detection and Classification of Bone Lesions on Staging Computed Tomography in Prostate Cancer: A Development StudyMason J Belue, Stephanie A Harmon, Dong Yang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 29, 2023
Joint EANM/SNMMI procedure guideline for the use of <sup>177</sup>Lu-labeled PSMA-targeted radioligand-therapy (<sup>177</sup>Lu-PSMA-RLT)Clemens Kratochwil, Wolfgang P Fendler, Matthias Eiber, et al.
JAMA Oncology|September 16, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled TrialDickran Kazandjian, Elizabeth Hill, Alexander Dew, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Radiology|July 8, 2020
Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of <sup>18</sup>F-DCFPyL PET/CT with Comparison to Multiparametric MRILiza Lindenberg, Esther Mena, Baris Turkbey, et al.
Leukemia & Lymphoma|December 23, 2015
Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imagingManisha Bhutani, Baris Turkbey, Esther Tan, et al.
AJR. American Journal of Roentgenology|October 16, 2019
Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective StudyBaris Turkbey, Marcin Czarniecki, Joanna H Shih, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2021
Predictors of <sup>18</sup>F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local TherapyEsther Mena, Steven P Rowe, Joanna H Shih, et al.
Oncotarget|March 4, 2021
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumorsNaoko Takebe, Geraldine O'Sullivan Coyne, Shivaani Kummar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2026
SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST)AeRang Kim, Karla V Ballman, Pamela L Wolters, et al.
Academic Radiology|January 23, 2024
Deep Learning-Based Detection and Classification of Bone Lesions on Staging Computed Tomography in Prostate Cancer: A Development StudyMason J Belue, Stephanie A Harmon, Dong Yang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 5, 2023
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 29, 2023
Joint EANM/SNMMI procedure guideline for the use of <sup>177</sup>Lu-labeled PSMA-targeted radioligand-therapy (<sup>177</sup>Lu-PSMA-RLT)Clemens Kratochwil, Wolfgang P Fendler, Matthias Eiber, et al.
JAMA Oncology|September 16, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled TrialDickran Kazandjian, Elizabeth Hill, Alexander Dew, et al.
Pageof 9